Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Phase 3 Interventional

An Efficacy and Safety Study for the Treatment of Mild to Moderate Acute Pain Associated With Ankle Strain or Sprain.

ClinicalTrials.gov ID: NCT02089425

Public ClinicalTrials.gov record NCT02089425. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 22, 2026, 5:49 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Study identification

NCT ID
NCT02089425
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 3
Lead sponsor
Kowa Research Institute, Inc.
Industry
Enrollment
384 participants

Conditions and interventions

Interventions

  • K-103-IP Drug
  • Placebo Drug

Drug

Eligibility (public fields only)

Age range
18 Years to 70 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Mar 31, 2014
Primary completion
Nov 30, 2014
Completion
Nov 30, 2014
Last update posted
Mar 2, 2017

2014

United States locations

U.S. sites
47
U.S. states
22
U.S. cities
47
Facility City State ZIP Site status
Not listed Birmingham Alabama
Not listed Phoenix Arizona
Not listed Tempe Arizona
Not listed Anaheim California
Not listed El Cajon California
Not listed Encinitas California
Not listed Los Angeles California
Not listed Ventura California
Not listed Boynton Beach Florida
Not listed Daytona Beach Florida
Not listed Doral Florida
Not listed Hialeah Florida
Not listed Jacksonville Florida
Not listed Kissimmee Florida
Not listed Miami Florida
Not listed Oldsmar Florida
Not listed Orlando Florida
Not listed Port Orange Florida
Not listed Chicago Illinois
Not listed Overland Park Kansas
Not listed Owensboro Kentucky
Not listed Towson Maryland
Not listed Rochester Michigan
Not listed St Louis Missouri
Not listed Great Falls Montana
Not listed Omaha Nebraska
Not listed Las Vegas Nevada
Not listed Atco New Jersey
Not listed New York New York
Not listed Charlotte North Carolina
Not listed Mooresville North Carolina
Not listed Morganton North Carolina
Not listed Cincinnati Ohio
Not listed Columbus Ohio
Not listed Dayton Ohio
Not listed Willoughby Ohio
Not listed Gresham Oregon
Not listed Rapid City South Dakota
Not listed Jackson Tennessee
Not listed Memphis Tennessee
Not listed Smyrna Tennessee
Not listed Austin Texas
Not listed Boerne Texas
Not listed El Paso Texas
Not listed Houston Texas
Not listed Bountiful Utah
Not listed Salt Lake City Utah

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02089425, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Mar 2, 2017 · Synced Jul 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT02089425 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →